HU
Heidelberg University Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Heidelberg University Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on artificial intelligence in oncology, from generative AI and autonomous agents to large language models in tumour boards and requirements for AI-based biomarkers. It also covers disease of the central nervous system, including glioblastoma, brain metastases and leptomeningeal disease.
| Organization | ESMO 2026 Attendance |
|---|---|
HU Heidelberg University Hospital Heidelberg, Germany | |
Teaching hospital of Heidelberg University in Heidelberg, Germany, and a site of the National Center for Tumor Diseases. | Talk Fri Oct 23 13:30–13:45 Chair Fri Oct 23 13:30–15:00 Keynote Fri Oct 23 15:20–15:40 CNS disease as the next frontier in oncology care: Glioblastoma, metastases, and leptomeningeal disease Sarcoma, CNS, head & neck and rare cancers Chair Sat Oct 24 08:30–10:00 Talk Sat Oct 24 09:10–09:30 |
Instantly find 20 buyers from Heidelberg University Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction